Director, US Market Access Analytics

About the role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: Reporting directly to the Vice President, US Analytics & Insights, the Director, Market Access Analytics will serve as the analytics and insights leader dedicated to US Market Access. This role will support launch planning and commercialization readiness by translating payer, reimbursement, contracting, channel, and patient access data into clear strategic guidance for the organization. Candidates should bring deep knowledge of the US market access landscape, strong analytical and business-partnering capabilities, and a track record of converting complex data into actionable recommendations in a fast-growing organization. Oncology and launch experience are strongly preferred. This position is based out of our headquarters in Redwood City, CA.

Responsibilities

• Serve as the Market Access Analytics lead on the US A&I team, developing and executing an integrated analytics plan that supports access strategy, launch readiness, performance monitoring, and business planning across the US portfolio.
• Act as a strategic thought partner to Market Access leadership and partners in Pricing & Contracting, Payer and Provider Account Management, Field Reimbursement, Patient Services, Trade and Distribution, Brand, Finance, HEOR, and Commercial Analytics.
• Own and evolve the market access KPI framework, establishing consistent definitions and executive-ready reporting across payer coverage and restrictions, contracting, channel performance, patient access and affordability, and field execution.
• Lead payer, formulary, and coverage analytics across commercial and government segments, including medical and pharmacy benefit dynamics, covered lives, utilization management, payer policy trends, account segmentation, and access opportunity assessments.
• Evaluate patient access and reimbursement performance by integrating patient-level claims, hub, specialty pharmacy, distribution, copay, and other relevant data to identify friction points, abandonment drivers, time-to-therapy trends, and opportunities to improve the patient journey.
• Support contracting decisions through analog assessments, post-contract performance measurement, pull-through analytics, and clear assessment of the financial and access implications of strategic options.
• Partner with Finance on gross-to-net assumptions and variance analyses; this role does not own forecasting or gross-to-net calculations.
• Develop and lead launch and in-market analytical capabilities, including payer archetyping and segmentation, access scenarios, account opportunity assessments, launch dashboards, early performance indicators, and post-launch diagnostic analyses.
• Integrate multiple evidence sources, including primary payer research, secondary data, competitive intelligence, policy and market developments, and HEOR evidence, to create a holistic view of access drivers, risks, and opportunities.
• Partner with Market Access, Information Systems and Data teams to inform data strategy and acquisition, business requirements, data quality standards, governance, and scalable reporting architecture while complying with applicable regulatory, security, and privacy requirements.
• Translate complex analyses into compelling recommendations and communicate the strength, limitations, implications, and recommended actions to senior leadership and cross-functional stakeholders.
• Drive adoption of fit